Recommended for primary and secondary prevention in patients at high risk of CVD
CAUTION: Rhabomyolysis: Check interactions (e.g. fibrates, dihydropyridines, antiinfectives)
Consider need for and intensity of treatment in light of life expectancy and ADR risk